39 studies found for:    " June 26, 2013":" July 26, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" June 26, 2013":" July 26, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated Evaluation of a Blood Test to Measure Immune Function in HIV Positive People Compared With HIV Negative People
Condition: HIV Positive
Intervention:
2 Recruiting Oligonucleotide Ligation Assay (OLA) Resistance Study
Condition: HIV Positive
Intervention: Other: Pre-ART Oligonucleotide Assay (OLA)
3 Completed Evaluation of the Impact of Mobile Phone Messages on ART and PMTCT Adherence in Mozambique
Condition: HIV-positive
Intervention: Behavioral: SMS reminders
4 Recruiting Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to Raltegravir
Conditions: HIV Infection;   Osteopenia
Interventions: Drug: raltegravir and atazanavir and ritonavir;   Drug: tenofovir/emtricitabine and atazanavir and ritonavir
5 Active, not recruiting Link4Health: A Combination Strategy for Linkage and Retention, Swaziland
Condition: HIV (Human Immunodeficiency Virus)
Interventions: Procedure: POC (point-of-care) CD4+ (cluster of differentiation 4) Count;   Procedure: Accelerated ART (antiretroviral therapy) Initiation;   Behavioral: Basic Care and Prevention Package;   Behavioral: Cellular Appointment Reminders and Follow-Up;   Other: Financial Incentive
6 Unknown  Viral Biofilms: Hijacking T Cell Extracellular Matrix to Regulate HIV-1 Spread?
Condition: HIV Infection
Intervention: Other: Blood sample
7 Active, not recruiting Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa
Condition: HIV Infection
Interventions: Drug: monoPI - boosted lopinavir or boosted darunavir;   Drug: bi therapy - (boosted lopinavir or boosted darunavir) + lamivudine
8 Unknown  A Prospective, Open-label Trial of Two Abacavir/Lamivudine Based Regimen (ABC/3TC + Darunavir/Ritonavir or ABC/3TC + Raltegravir) in Late Presenter naïve Patients (With CD4 Count <200 Cells/µL - Advanced HIV Disease)
Condition: HIV Infection
Interventions: Drug: abacavir/lamivudine + raltegravir;   Drug: abacavir/lamivudine + darunavir/ritonavir
9 Completed Juvenile Detention to Community Life
Conditions: Substance Use;   Delinquency;   Risk for HIV Infection
Interventions: Behavioral: Multidimensional Family Therapy Cross-Systems;   Behavioral: Enhanced Services as Usual
10 Completed Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions
Conditions: Human Immunodeficiency Virus;   Hepatitis B, Chronic;   Hepatitis C, Chronic
Intervention: Drug: antiretroviral drugs
11 Active, not recruiting A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir/abacavir/lamivudine FDC;   Drug: Atazanavir;   Drug: Ritonavir;   Drug: Tenofovir/emtricitabine FDC
12 Completed Male Engagement in PMTCT Services
Condition: HIV
Interventions: Other: clinic based intervention;   Other: clinic and community based intervention
13 Unknown  CHANGES IN LIVER STEATOSIS AFTER SWITCHING TO RALTEGRAVIR IN HIV/HCV COINFECTION
Conditions: HCV Coinfection;   HIV Infection
Interventions: Drug: Raltegravir;   Drug: Efavirenz
14 Withdrawn Evaluating the Safety and Immune Response of DNA/MVA Vaccines in HIV-1-Infected Young Adults Taking Anti-HIV Medications
Condition: HIV Infections
Interventions: Biological: GEO-D03 DNA Vaccine;   Biological: MVA/HIV62B Vaccine;   Biological: Placebo for DNA GEO-D03;   Biological: Placebo for MVA/HIV62B Vaccine
15 Completed An Observational Study of Induction Therapy With Fuzeon (Enfuvirtide) in Combination With Antiretroviral Drugs in Patients With HIV-1 Infection
Condition: HIV Infections
Intervention:
16 Completed Maternal HIV Disclosure to School Children: RCT of Family-based Intervention
Conditions: HIV;   Disclosure
Intervention: Behavioral: Amagugu Counseling Intervention
17 Unknown  Investigating Immunisation Strategies of DNA, MVA and CN54rgp140 Adjuvanted With GLA-AF to Maximise Antibody Responses
Condition: HIV
Interventions: Biological: DNA;   Biological: MVA-C;   Biological: CN54rgp140;   Biological: GLA-AF
18 Completed Mfangano Island Healthy Networks Impact Study
Condition: HIV
Intervention: Behavioral: Mfangano Health Net Microclinic Program
19 Completed Prospective HIV Chemotherapy Cohort Study
Conditions: HIV;   Cancer
Intervention: Other: No intervention for this study
20 Unknown  Relaxation, Depressive Symptoms, Quality of Life, Immunological and Virological Status in People Living With HIV: a Pilot Study
Conditions: HIV;   Depressive Symptoms
Interventions: Behavioral: Jacobson progressive muscular relaxation;   Behavioral: Schultz's autogenic training

   Previous Page Studies Shown (1-20) Next Page (21-39) Show next page of results    Last Page
Indicates status has not been verified in more than two years